Brief: Park City says signed agreement with bio-pharmaceutical manufacturer to pilot repositrak's Track & Trace solution
Sept 22 (Reuters) - Park City Group Inc PCYG.O : * Says signed agreement with bio-pharmaceutical manufacturer to pilot repositrak's track & trace solution * Repositrak will provide manufacturer with visibility to product movement through supply chain and guard against entry of counterfeit drugs * Source text for Eikon ID:nBw9wkLVza * Further company coverage PCYG.O ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Repositrak
See all newsBrief: Large National Dairy Achieves 17% Sales Lift With Repositrak Touchless Retail
ReposiTrak Inc reports results for the quarter ended March 31 - Earnings Summary
Repositrak Q4 revenue falls
ReposiTrak Inc expected to post earnings of 9 cents a share - Earnings Preview
Brief: Repositrak May Offer Up To $35 Million In Common Stock, Preferred Stock, Warrants, Or Units - SEC Filing